Bosentan Patent Expiration

1. Tracleer patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5292740 ACTELION Sulfonamides
Nov, 2015

(8 years ago)

US8309126 ACTELION Dispersible bosentan tablet
May, 2026

(1 year, 9 months from now)

US7959945 ACTELION Dispersible bosentan tablet
Dec, 2027

(3 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-607) Aug 07, 2012
New Patient Population(NPP) Sep 05, 2020
ODE*(ODE*) Sep 05, 2024

Market Authorisation Date: 20 November, 2001

Treatment: NA

Dosage: TABLET; TABLET, FOR SUSPENSION

How can I launch a generic of TRACLEER before it's drug patent expiration?
More Information on Dosage

TRACLEER family patents

Family Patents